Karnataka intensifies drug pricing crackdown, Centre seeks expanded raids

State authorities in Karnataka have announced plans to escalate raids targeting pharmaceutical retailers and distributors accused of applying substantial markups to high-cost medications. The enforcement action, coordinated with the Centre, aims to address pricing disparities that significantly impact patient affordability across multiple drug categories.

The next phase of the crackdown will concentrate on antiretroviral drugs used in HIV treatment, higher-generation antibiotics, and critical medical devices, alongside hospital consumables. Officials have identified these segments as areas where markup practices create substantial financial burden for patients and healthcare institutions alike.

Karnataka's communication to the Union government indicates a coordinated approach to pharmaceutical pricing regulation. State authorities have requested central government backing to ensure consistency in enforcement and to address distribution-level pricing practices that may circumvent official price guidelines.

The enforcement initiative reflects growing scrutiny of medicine pricing chains in India, where multiple intermediaries between manufacturers and consumers can inflate final costs. Patients, particularly those requiring long-term treatment for conditions such as HIV/AIDS or serious infections, have faced significant out-of-pocket expenses due to such markups.

The raids represent part of a broader effort to ensure compliance with pharmaceutical pricing norms and to protect consumer interests in the healthcare supply chain. Authorities indicated that subsequent phases of the operation would continue targeting sectors where excessive profiteering undermines medication accessibility.